Long-Term Neurodevelopmental Risks in Children Exposed in Utero to Cocaine: The Toronto Adoption Studya

Gideon Koren1, Irena Nulman1, Joanne Rovet1

  • 1Motherisk Program, bDivisions of Clinical Pharmacology and dPsychology Research, b,dThe Research Institute; The Hospital for Sick Children, and b,c,dDepartment of Pediatrics, Pharmacology University of Toronto, Toronto, Ontario, CanadaPsychology, University of Toronto, Toronto, Ontario, CanadaFaculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

Insights

Children exposed to cocaine in utero face neurobehavioral risks. Adoption studies reveal cocaine

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Public Health

Background:

  • Prenatal cocaine exposure is linked to neurobehavioral deficits.
  • Confounding factors like socioeconomic status and maternal addiction complicate direct toxicity assessment.
  • Adoption studies offer a method to isolate drug effects.

Purpose of the Study:

  • To determine the direct neurotoxic effects of prenatal cocaine exposure.
  • To differentiate cocaine's impact from environmental and social factors.
  • To quantify effects on cognitive and language development.

Main Methods:

  • Utilizing the Toronto Adoption Study cohort.
  • Comparing children exposed prenatally to cocaine and adopted into higher socioeconomic families.
  • Assessing neurobehavioral outcomes including IQ and language skills.

Main Results:

  • Prenatal cocaine exposure has direct, mild to moderate neurotoxic effects on IQ and language.
  • These effects are less severe than in children exposed and reared by their biological mothers.
  • Adoption into supportive environments mitigates some negative outcomes.

Conclusions:

  • Prenatal cocaine exposure causes identifiable neurodevelopmental deficits.
  • Environmental factors significantly influence the severity of these deficits.
  • Targeted interventions and supportive environments can ameliorate negative outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.